EE195 Cost-Effectiveness Analysis of CYP2C19 Genotype-Guided Antiplatelet Therapy for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention in the Netherlands
Abstract
Authors
Kamila Shiba ZHUOLIN ZHANG Eelko Hak Frank Klont Talitha Feenstra